Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.

Clicks: 105
ID: 282912
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 3 articles by views in gastroenterology clinics of north america

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Bacteria are associated with certain cancers and may induce genetic instability and cancer progression. The gut microbiome modulates the response to cancer therapy. Training machine learning models with response associated taxa or bacterial genes predict patients' response to immunotherapies with moderate accuracy. Clinical trials targeting the gut microbiome to improve immunotherapy efficacy have been conducted. While single bacterial strains or small consortia have not be reported yet to be successful, encouraging results have been reported in small single arm and randomized studies using transplant of fecal microbiome from cancer patients who successfully responded to therapy or from healthy volunteers.
Reference Key
silveira2025intestinal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Silveira, Maruhen A D; Rodrigues, Richard R; Trinchieri, Giorgio
Journal gastroenterology clinics of north america
Year 2025
DOI
10.1016/j.gtc.2024.10.005
URL
Keywords
Cancer cancer therapy immunotherapy gut bacteria microbiome fecal microbiome transplant machine learning prediction

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.